BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14684241)

  • 1. Hypoalbuminemia with valproic acid administration.
    Rugino TA; Janvier YM; Baunach JM; Bilat CA
    Pediatr Neurol; 2003 Nov; 29(5):440-4. PubMed ID: 14684241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report on reversible Pelger-Huët anomaly depending on serum free fraction of valproic acid.
    Suzuki K; Hiramoto A; Okumura T
    Brain Dev; 2015 Mar; 37(3):344-6. PubMed ID: 24985021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of free fraction valproic acid in patients with hypoalbuminaemia.
    Jansen AJ; Hunfeld NG; van Bommel J; Koch BC; van Gelder T
    Neth J Med; 2012 Sep; 70(7):329. PubMed ID: 22961830
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
    Dasgupta A; McLemore JL
    Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
    de Maat MM; van Leeuwen HJ; Edelbroek PM
    Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review.
    Sinclair DB; Berg M; Breault R
    J Child Neurol; 2004 Jul; 19(7):498-502. PubMed ID: 15526953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
    Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
    J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
    Eberl W; Budde U; Bentele K; Christen HJ; Knapp R; Mey A; Schneppenheim R
    Hamostaseologie; 2009 May; 29(2):137-42. PubMed ID: 19404518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Lunde JL; Nelson RE; Storandt HF
    Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.
    Riker RR; Gagnon DJ; Hatton C; May T; Seder DB; Stokem K; Fraser GL
    Pharmacotherapy; 2017 Apr; 37(4):500-508. PubMed ID: 28173638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions.
    Wassef AA; Winkler DE; Roache AL; Abobo VB; Lopez LM; Averill JP; Mian AI; Overall JE
    Am J Psychiatry; 2005 Feb; 162(2):330-9. PubMed ID: 15677599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state.
    Yoshikawa H; Yamazaki S; Watanabe T; Abe T
    Brain Dev; 2003 Apr; 25(3):186-90. PubMed ID: 12689697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH; Kong CK; Tse PW
    Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia.
    Doré M; San Juan AE; Frenette AJ; Williamson D
    Pharmacotherapy; 2017 Aug; 37(8):900-907. PubMed ID: 28574586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion.
    Cook AM; Zafar MS; Mathias S; Stewart AM; Albuja AC; Bensalem-Owen M; Kapoor S; Baumann RJ
    CNS Drugs; 2016 Jan; 30(1):71-7. PubMed ID: 26715390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 17. Duration of valproic acid monotherapy correlates with subclinical thyroid dysfunction in children with epilepsy.
    Ilić V; Bogićević D; Miljković B; Ješić M; Kovačević M; Prostran M; Kovačević SV
    Epileptic Disord; 2016 Jun; 18(2):181-6. PubMed ID: 27099936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of rapid valproic acid infusion.
    Limdi NA; Faught E
    Epilepsia; 2000 Oct; 41(10):1342-5. PubMed ID: 11051132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine deficiency associated with anticonvulsant therapy.
    Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R
    Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.